⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for recurrent adult soft tissue sarcoma

Every month we try and update this database with for recurrent adult soft tissue sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Selumetinib With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By SurgeryNCT01206140
Recurrent Adult...
Stage III Adult...
Stage IV Adult ...
Laboratory Biom...
Selumetinib
Temsirolimus
18 Years - National Cancer Institute (NCI)
Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial SarcomaNCT00052754
Sarcoma
gefitinib
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Nitrocamptothecin in Treating Patients With Soft Tissue SarcomasNCT00005874
Gastrointestina...
Sarcoma
Small Intestine...
rubitecan
- National Cancer Institute (NCI)
Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue SarcomaNCT00004123
Sarcoma
Doxorubicin hyd...
Conventional su...
Intraoperative ...
Radiation Thera...
18 Years - M.D. Anderson Cancer Center
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory RhabdomyosarcomaNCT01222715
Adult Rhabdomyo...
Childhood Alveo...
Childhood Pleom...
Childhood Rhabd...
Previously Trea...
Recurrent Adult...
Recurrent Child...
Bevacizumab
Cyclophosphamid...
Laboratory Biom...
Temsirolimus
Vinorelbine Tar...
- 29 YearsNational Cancer Institute (NCI)
Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue SarcomaNCT01281865
Adult Synovial ...
Recurrent Adult...
Stage III Adult...
Stage IV Adult ...
diagnostic labo...
everolimus
imatinib mesyla...
18 Years - National Cancer Institute (NCI)
S0505 Sorafenib in Treating Patients With Advanced Soft Tissue SarcomasNCT00217620
Sarcoma
sorafenib
18 Years - National Cancer Institute (NCI)
Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue SarcomaNCT00002764
Endometrial Can...
Kidney Cancer
Metastatic Canc...
Ovarian Cancer
Pheochromocytom...
Sarcoma
filgrastim
doxorubicin hyd...
ifosfamide
conventional su...
16 Years - European Organisation for Research and Treatment of Cancer - EORTC
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By SurgeryNCT01553539
Bone Cancer
Chondrosarcoma
Clear Cell Sarc...
Metastatic Oste...
Ovarian Sarcoma
Recurrent Adult...
Recurrent Osteo...
Recurrent Uteri...
Stage III Adult...
Stage III Uteri...
Stage IV Adult ...
Stage IV Uterin...
therapeutic ang...
laboratory biom...
18 Years - Wake Forest University Health Sciences
Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue SarcomaNCT01281865
Adult Synovial ...
Recurrent Adult...
Stage III Adult...
Stage IV Adult ...
diagnostic labo...
everolimus
imatinib mesyla...
18 Years - National Cancer Institute (NCI)
A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue SarcomasNCT01782313
Recurrent Adult...
Stage III Adult...
Stage IV Adult ...
tivozanib
laboratory biom...
18 Years - Northwestern University
Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue SarcomaNCT00064220
Sarcoma
soblidotin
15 Years - Daiichi Sankyo
STI571 in Treating Patients With Recurrent or Refractory Soft Tissue SarcomaNCT00006357
Endometrial Can...
Gastrointestina...
Ovarian Cancer
Sarcoma
Small Intestine...
imatinib mesyla...
15 Years - European Organisation for Research and Treatment of Cancer - EORTC
Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain TumorNCT00069940
Brain and Centr...
Gastrointestina...
Sarcoma
sargramostim
telomerase: 540...
2 Years - Dana-Farber Cancer Institute
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's LymphomaNCT00082823
Cancer
ziv-aflibercept
18 Years - 120 YearsRegeneron Pharmaceuticals
Studying Genes in Samples From Younger Patients With Desmoplastic Small Round Cell Tumor Registered on COG-D9902 or COG-ABTR01B1NCT01430637
Sarcoma
DNA analysis
RNA analysis
gene expression...
mutation analys...
nucleic acid se...
polymerase chai...
laboratory biom...
pharmacogenomic...
- 50 YearsChildren's Oncology Group
Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue SarcomaNCT00004066
Ovarian Cancer
Sarcoma
Small Intestine...
filgrastim
docetaxel
gemcitabine hyd...
18 Years - Memorial Sloan Kettering Cancer Center
Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the BrainNCT00550654
Kidney Cancer
Melanoma (Skin)
Metastatic Canc...
Ovarian Cancer
Sarcoma
Unspecified Adu...
questionnaire a...
3-dimensional c...
hypofractionate...
image-guided ra...
tomotherapy
18 Years - National Institutes of Health Clinical Center (CC)
A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue SarcomasNCT01782313
Recurrent Adult...
Stage III Adult...
Stage IV Adult ...
tivozanib
laboratory biom...
18 Years - Northwestern University
Combination of Cryosurgery and NK Immunotherapy for Recurrent SarcomaNCT02849366
Recurrent Adult...
Cryosurgery
NK immunotherap...
30 Years - 70 YearsFuda Cancer Hospital, Guangzhou
Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone SarcomaNCT01016015
Metastatic Oste...
Recurrent Adult...
Recurrent Osteo...
Stage III Adult...
Stage IV Adult ...
Cixutumumab
Laboratory Biom...
Temsirolimus
16 Years - National Cancer Institute (NCI)
BMS-247550 in Treating Patients With Advanced Soft Tissue SarcomaNCT00022542
Recurrent Adult...
Stage III Adult...
Stage IV Adult ...
ixabepilone
18 Years - National Cancer Institute (NCI)
Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue SarcomaNCT00053794
Endometrial Can...
Sarcoma
perifosine
18 Years - 120 YearsCanadian Cancer Trials Group
Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial SarcomaNCT00104949
Sarcoma
trastuzumab
18 Years - National Cancer Institute (NCI)
Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By SurgeryNCT00098579
Gastrointestina...
Recurrent Adult...
Stage IV Adult ...
alvocidib
doxorubicin hyd...
18 Years - National Cancer Institute (NCI)
Pazopanib Hydrochloride in Treating Patients With Advanced AngiosarcomaNCT01462630
Adult Angiosarc...
Recurrent Adult...
Stage III Adult...
Stage IV Adult ...
pazopanib hydro...
laboratory biom...
positron emissi...
computed tomogr...
fludeoxyglucose...
18 Years - Fox Chase Cancer Center
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue SarcomaNCT00004261
Breast Cancer
Cervical Cancer
Head and Neck C...
Prostate Cancer
Sarcoma
EF5
flow cytometry
fluorescent ant...
immunohistochem...
biopsy
18 Years - 120 YearsUniversity Health Network, Toronto
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid TumorsNCT00002608
Adrenocortical ...
Brain and Centr...
Head and Neck C...
Liver Cancer
Malignant Mesot...
Pheochromocytom...
Sarcoma
cisplatin
doxorubicin hyd...
tamoxifen citra...
conventional su...
radiation thera...
- 65 YearsNational Cancer Institute (NCI)
Bevacizumab in Treating Patients With AngiosarcomaNCT00288015
Sarcoma
Bevacizumab
18 Years - Northwestern University
Chemotherapy in Treating Patients With Advanced SarcomaNCT00002526
Ovarian Cancer
Sarcoma
filgrastim
doxorubicin hyd...
ifosfamide
18 Years - 70 YearsSwiss Group for Clinical Cancer Research
BI 2536 in Treating Patients With Recurrent or Metastatic Solid TumorsNCT00526149
Breast Cancer
Endometrial Can...
Head and Neck C...
Melanoma (Skin)
Ovarian Cancer
Sarcoma
BI 2536
high performanc...
mass spectromet...
pharmacological...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Cryosurgery in Treating Patients With Soft Tissue SarcomaNCT00002863
Sarcoma
chemotherapy
conventional su...
cryosurgery
- University of Southern California
Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue SarcomaNCT00023738
Sarcoma
filgrastim
dacarbazine
doxorubicin hyd...
ifosfamide
semaxanib
conventional su...
radiation thera...
18 Years - National Cancer Institute (NCI)
CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue SarcomaNCT00017446
Sarcoma
CP4071
18 Years - National Cancer Institute (NCI)
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic CancerNCT00436410
Adrenocortical ...
Breast Cancer
Colorectal Canc...
Gastrointestina...
Kidney Cancer
Liver Cancer
Melanoma (Skin)
Ovarian Cancer
Pancreatic Canc...
Sarcoma
colloidal gold-...
electron micros...
pharmacological...
conventional su...
18 Years - National Institutes of Health Clinical Center (CC)
Nitrocamptothecin in Treating Patients With Soft Tissue SarcomasNCT00005874
Gastrointestina...
Sarcoma
Small Intestine...
rubitecan
- National Cancer Institute (NCI)
Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced AngiosarcomaNCT02048722
Adult Angiosarc...
Recurrent Adult...
Stage III Adult...
Stage IV Adult ...
regorafenib
18 Years - Northwestern University
Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue SarcomaNCT00023738
Sarcoma
filgrastim
dacarbazine
doxorubicin hyd...
ifosfamide
semaxanib
conventional su...
radiation thera...
18 Years - National Cancer Institute (NCI)
Rosiglitazone in Treating Patients With LiposarcomaNCT00004180
Sarcoma
rosiglitazone m...
18 Years - Dana-Farber Cancer Institute
Vaccine Therapy and Sargramostim in Treating Patients With Soft Tissue SarcomaNCT00027911
Sarcoma
NY-ESO-1 peptid...
sargramostim
18 Years - Columbia University
Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable LiposarcomaNCT00233948
Adult Liposarco...
Recurrent Adult...
Stage III Adult...
Stage IV Adult ...
nelfinavir mesy...
biopsy
laboratory biom...
pharmacological...
gene expression...
western blottin...
reverse transcr...
immunoenzyme te...
18 Years - City of Hope Medical Center
Ecteinascidin 743 in Treating Patients With Unresectable Advanced or Metastatic Soft Tissue SarcomaNCT00017030
Sarcoma
trabectedin
18 Years - National Cancer Institute (NCI)
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerNCT00087191
Advanced Adult ...
Carcinoma of th...
Fallopian Tube ...
Gastrointestina...
Localized Extra...
Localized Gallb...
Localized Gastr...
Localized Resec...
Localized Unres...
Metastatic Gast...
Ovarian Sarcoma
Ovarian Stromal...
Primary Periton...
Recurrent Adult...
Recurrent Adult...
Recurrent Colon...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Recta...
Recurrent Small...
Recurrent Uteri...
Regional Gastro...
Small Intestine...
Small Intestine...
Small Intestine...
Stage 0 Non-sma...
Stage I Adult S...
Stage I Colon C...
Stage I Gastric...
Stage I Non-sma...
Stage I Ovarian...
Stage I Ovarian...
Stage I Pancrea...
Stage I Rectal ...
Stage I Uterine...
Stage II Adult ...
Stage II Colon ...
Stage II Gastri...
Stage II Non-sm...
Stage II Ovaria...
Stage II Ovaria...
Stage II Pancre...
Stage II Rectal...
Stage II Uterin...
Stage III Adult...
Stage III Colon...
Stage III Gastr...
Stage III Ovari...
Stage III Ovari...
Stage III Pancr...
Stage III Recta...
Stage III Uteri...
Stage IIIA Non-...
Stage IIIB Non-...
Stage IV Adult ...
Stage IV Colon ...
Stage IV Gastri...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Rectal...
Stage IV Uterin...
Unresectable Ex...
Unresectable Ga...
EF5
motexafin lutet...
pharmacological...
18 Years - National Cancer Institute (NCI)
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue SarcomaNCT00003939
Brain and Centr...
Endometrial Can...
Gastrointestina...
Ovarian Cancer
Sarcoma
Small Intestine...
trabectedin
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue SarcomaNCT00919269
Adult Rhabdomyo...
Childhood Desmo...
Chordoma
Desmoid-Type Fi...
Metastatic Chil...
Non-Metastatic ...
Previously Trea...
Recurrent Adult...
Recurrent Child...
Recurrent Child...
Rhabdomyosarcom...
Stage I Adult S...
Stage II Adult ...
Stage III Adult...
Stage IV Adult ...
Untreated Child...
Cytology Specim...
Laboratory Biom...
- 50 YearsChildren's Oncology Group
Exatecan Mesylate in Treating Patients With Advanced Soft Tissue SarcomaNCT00041236
Sarcoma
exatecan mesyla...
15 Years - 75 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell FibroblastomaNCT00085475
Sarcoma
imatinib mesyla...
conventional su...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue SarcomaNCT00004109
Sarcoma
Doxorubicin Hyd...
Radiation Thera...
16 Years - M.D. Anderson Cancer Center
BI 2536 in Treating Patients With Recurrent or Metastatic Solid TumorsNCT00526149
Breast Cancer
Endometrial Can...
Head and Neck C...
Melanoma (Skin)
Ovarian Cancer
Sarcoma
BI 2536
high performanc...
mass spectromet...
pharmacological...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue SarcomaNCT00937495
Recurrent Adult...
Stage III Adult...
Stage IV Adult ...
vorinostat
bortezomib
18 Years - National Cancer Institute (NCI)
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By SurgeryNCT01553539
Bone Cancer
Chondrosarcoma
Clear Cell Sarc...
Metastatic Oste...
Ovarian Sarcoma
Recurrent Adult...
Recurrent Osteo...
Recurrent Uteri...
Stage III Adult...
Stage III Uteri...
Stage IV Adult ...
Stage IV Uterin...
therapeutic ang...
laboratory biom...
18 Years - Wake Forest University Health Sciences
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's LymphomaNCT00083213
Cancer
ziv-aflibercept
18 Years - 120 YearsRegeneron Pharmaceuticals
Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue SarcomaNCT00041249
Gastrointestina...
Sarcoma
brostallicin
15 Years - European Organisation for Research and Treatment of Cancer - EORTC
Alisertib in Treating Patients With Advanced or Metastatic SarcomaNCT01653028
Myxofibrosarcom...
Recurrent Adult...
Recurrent Leiom...
Recurrent Lipos...
Recurrent Malig...
Recurrent Undif...
Stage III Soft ...
Stage IV Soft T...
Alisertib
Laboratory Biom...
18 Years - National Cancer Institute (NCI)
Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma ProtuberansNCT00084630
Adult Fibrosarc...
Dermatofibrosar...
Recurrent Adult...
Stage IV Adult ...
imatinib mesyla...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Vaccine Therapy in Treating Patients With Recurrent Soft Tissue SarcomaNCT00005628
Sarcoma
vitespen
18 Years - Memorial Sloan Kettering Cancer Center
S0505 Sorafenib in Treating Patients With Advanced Soft Tissue SarcomasNCT00217620
Sarcoma
sorafenib
18 Years - National Cancer Institute (NCI)
Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable LeiomyosarcomaNCT00033709
Sarcoma
temozolomide
thalidomide
18 Years - National Cancer Institute (NCI)
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue SarcomaNCT00003939
Brain and Centr...
Endometrial Can...
Gastrointestina...
Ovarian Cancer
Sarcoma
Small Intestine...
trabectedin
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath TumorNCT00068367
Sarcoma
erlotinib hydro...
18 Years - 120 YearsSWOG Cancer Research Network
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for CancerNCT01132547
Cancer
cyproheptadine ...
placebo
2 Years - 21 YearsUniversity of South Florida
Selumetinib With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By SurgeryNCT01206140
Recurrent Adult...
Stage III Adult...
Stage IV Adult ...
Laboratory Biom...
Selumetinib
Temsirolimus
18 Years - National Cancer Institute (NCI)
Bevacizumab in Treating Patients With AngiosarcomaNCT00288015
Sarcoma
Bevacizumab
18 Years - Northwestern University
Troglitazone in Treating Patients With LiposarcomaNCT00003058
Sarcoma
troglitazone
18 Years - 120 YearsDana-Farber Cancer Institute
Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue SarcomaNCT00937495
Recurrent Adult...
Stage III Adult...
Stage IV Adult ...
vorinostat
bortezomib
18 Years - National Cancer Institute (NCI)
Pazopanib Hydrochloride in Treating Patients With Advanced AngiosarcomaNCT01462630
Adult Angiosarc...
Recurrent Adult...
Stage III Adult...
Stage IV Adult ...
pazopanib hydro...
laboratory biom...
positron emissi...
computed tomogr...
fludeoxyglucose...
18 Years - Fox Chase Cancer Center
Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By SurgeryNCT00217607
Sarcoma
paclitaxel
18 Years - 70 YearsUNICANCER
Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue SarcomaNCT00002641
Endometrial Can...
Kidney Cancer
Ovarian Cancer
Pheochromocytom...
Sarcoma
filgrastim
doxorubicin hyd...
ifosfamide
isolated perfus...
adjuvant therap...
conventional su...
radiation thera...
16 Years - 69 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue SarcomaNCT00423618
Sarcoma
radiotherapy
16 Years - 120 YearsSheffield Teaching Hospitals NHS Foundation Trust
Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue SarcomaNCT00740597
Sarcoma
gene expression...
polymerase chai...
western blottin...
neoadjuvant the...
therapeutic con...
intensity-modul...
18 Years - City of Hope Medical Center
Exatecan Mesylate in Treating Patients With Advanced Soft Tissue SarcomaNCT00041236
Sarcoma
exatecan mesyla...
15 Years - 75 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue SarcomaNCT00004066
Ovarian Cancer
Sarcoma
Small Intestine...
filgrastim
docetaxel
gemcitabine hyd...
18 Years - Memorial Sloan Kettering Cancer Center
Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue SarcomaNCT00410462
Ovarian Cancer
Sarcoma
Small Intestine...
brostallicin
doxorubicin hyd...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Doxorubicin and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Soft Tissue SarcomaNCT00052390
Sarcoma
bevacizumab
doxorubicin hyd...
18 Years - National Cancer Institute (NCI)
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue SarcomaNCT00004261
Breast Cancer
Cervical Cancer
Head and Neck C...
Prostate Cancer
Sarcoma
EF5
flow cytometry
fluorescent ant...
immunohistochem...
biopsy
18 Years - 120 YearsUniversity Health Network, Toronto
CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue SarcomaNCT00017446
Sarcoma
CP4071
18 Years - National Cancer Institute (NCI)
Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced AngiosarcomaNCT02048722
Adult Angiosarc...
Recurrent Adult...
Stage III Adult...
Stage IV Adult ...
regorafenib
18 Years - Northwestern University
Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body WallNCT00089544
Recurrent Adult...
Stage I Adult S...
Stage II Adult ...
Stage III Adult...
Dacarbazine
Doxorubicin Hyd...
Filgrastim
Ifosfamide
Laboratory Biom...
Radiation Thera...
Thalidomide
Therapeutic Con...
16 Years - National Cancer Institute (NCI)
Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue SarcomaNCT00003719
Sarcoma
irinotecan hydr...
18 Years - National Cancer Institute (NCI)
Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial SarcomaNCT00052754
Sarcoma
gefitinib
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: